BioSpace News Archive

Business

NHCAA Elects New Board Chair Sara “Sally” Walker

Sara “Sally” Walker, Vice President, Enterprise Risk Management at Blue Cross Blue Shield of Massachusetts elected as 2020 Chair of the NHCAA Board of Directors

October 15, 2019
·
3 min read
Business

Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019

Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the “Company” or “Valens”), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab is pleased to report its financial results for the third quarter of fiscal 2019.

October 15, 2019
·
9 min read
Drug Development

Denovo Biopharma Receives FDA’s Permission to Proceed with a Biomarker-Guided Phase 2b Clinical Trial with DB102 (Enzastaurin) In First-Line Treatment of Glioblastoma (GBM)

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced FDA’s approval to initiate Denovo’s Phase 2b clinical study of DB102 in patients with newly-diagnosed glioblastoma (GBM) in combination with radiation and temozolomide.

October 15, 2019
·
2 min read
Business

Genomma Lab Internacional, S.A.B. de C.V. Third Quarter 2019 Results Conference Call

Genomma Lab cordially invites you to join its quarterly conference call to discuss results for the third quarter of 2019.

October 15, 2019
·
2 min read